2 withdrawn. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Withdrawn 2 |
Follow Aspergillosis: new trials by email Literature Review of Aspergillosis trials Research Report on Aspergillosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Benralizumab in the Treatment of Patients With Severe Asthma With ABPA Fasenra, 30 Mg/mL Subcutaneous Solution - ABPA, Severe Asthma | Phase 4 | Withdrawn | Baylor Research Institute | 2019-12-23 | 2022-02-01 | |
| A Study to Evaluate the Effectiveness of Voriconazole + Micafungin Versus Voriconazole Alone for Invasive Aspergillosis micafungin, voriconazole - Aspergillosis/Blood, Aspergillosis/Invasive | Phase 4 | Withdrawn | Astellas Pharma Inc | 2007-02-01 | 2015-09-02 |
Aspergillosis, Allergic Bronchopulmonary (1) · Asthma (1)
Bacterial Infections and Mycoses (2) · Infections (2) · Mycoses (2) · Bronchial Diseases (1) · Hypersensitivity (1) · Hypersensitivity, Immediate (1) · Immune System Diseases (1) · Lung Diseases (1) · Lung Diseases, Fungal (1) · Lung Diseases, Obstructive (1) · Pulmonary Aspergillosis (1) · Respiratory Hypersensitivity (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1)
Micafungin (1) · Voriconazole (1) · benralizumab (1)
Astellas Pharma Inc (1) · Baylor Research Institute (1)
United States (2)